학술논문
Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
Document Type
Article
Author
Source
In: Haematologica . (Haematologica, March 2024, 109(3):895-905)
Subject
Language
English
ISSN
15928721
03906078
03906078